The U.S. healthcare system has had a hard time digesting the recent debut of Sovaldi and Harvoni, two drugs that have proven effective in curing hepatitis C but cost close to $100,000 for a regimen....
A New York City physician with a master's degree in public health has come to the conclusion that it would have been cheaper for her to have asked for the cash-pay price for her hospital to perform a mammogram than having it billed through her insurance company, according to MedPage Today.
When it comes to population health management, retail health clinics have an important role that includes not only immunizing patients against the flu virus but coaching chronically ill patients in disease management programs, Peter Goldbach, M.D., chief medical officer of RediClinic, said in an interview with HealthITAnalytics.
There are myriad apps, tools and technologies entering the healthcare marketplace--but most lack proof that they are helping consumers battle disease and stay healthy.
As hospitals become increasingly willing to listen to nurses' opinions in healthcare facility design, a book coming out this fall will help guide nurses through the redesign process. Multiple contributors will discuss topics including innovations led by nurses and trends affecting design.
Adults 65 years and older are at an increased risk of contracting influenza, pneumococcus and hepatitis B. However, health insurers, providers and pharmacies can help consumers access the care they need through a variety of methods, according to a new report from America's Health Insurance Plans.
A wireless sensor system used to monitor elderly people at assisted living facilities and at home is helping to detect illness and keep them out of the hospital.
Two more participants may exit the Pioneer ACO program due to lackluster financial performance--just days after the Centers for Medicare & Medicaid Services announced its accountable care organizations saved $411 million last year.
Working late hours doesn't affect surgeons' skills, according to a new study in the New England Journal of Medicine.
The Health Resources Services Administration has released its long-awaited "mega-guidance" for the 340B discount drug program.